|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
41,630,000 |
Market
Cap: |
26.95(M) |
Last
Volume: |
204,752 |
Avg
Vol: |
425,452 |
52
Week Range: |
$0.6474 - $0.6474 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
166,159 |
Total Buy Value |
$0 |
$0 |
$0 |
$81,668 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bedrosian Arthur P |
CEO |
|
2014-12-15 |
4 |
AS |
$43.81 |
$219,050 |
D/D |
(5,000) |
623,952 |
|
- |
|
Farber David |
10% Owner |
|
2014-12-15 |
4 |
AS |
$43.81 |
$219,050 |
D/D |
(5,000) |
30,870 |
|
- |
|
Galvan Martin P |
VP of Finance & CFO |
|
2014-12-10 |
4 |
B |
$42.37 |
$42,400 |
D/D |
1,000 |
32,499 |
2.74 |
- |
|
Maher James M. |
Director |
|
2014-12-10 |
4 |
B |
$42.96 |
$10,740 |
D/D |
250 |
11,750 |
2.39 |
- |
|
Sabo Ernest |
VP, Regulatory and CCO |
|
2014-12-08 |
4 |
S |
$48.03 |
$288,180 |
D/D |
(6,000) |
23,395 |
|
- |
|
Sabo Ernest |
VP, Regulatory and CCO |
|
2014-12-08 |
4 |
OE |
$3.55 |
$21,300 |
D/D |
6,000 |
29,395 |
|
- |
|
Maher James M. |
Director |
|
2014-12-02 |
4 |
B |
$46.53 |
$23,265 |
D/D |
500 |
11,500 |
2.39 |
- |
|
Sabo Ernest |
VP, Regulatory and CCO |
|
2014-11-26 |
4 |
S |
$50.04 |
$150,120 |
D/D |
(3,000) |
23,395 |
|
- |
|
Sabo Ernest |
VP, Regulatory and CCO |
|
2014-11-26 |
4 |
OE |
$3.55 |
$10,650 |
D/D |
3,000 |
26,395 |
|
- |
|
Farber David |
10% Owner |
|
2014-11-26 |
4 |
AS |
$50.00 |
$375,000 |
D/D |
(7,500) |
35,870 |
|
- |
|
Farber Jeffrey |
Director |
|
2014-11-25 |
5 |
GD |
$0.00 |
$0 |
D/D |
14,600 |
785,370 |
|
- |
|
Maher James M. |
Director |
|
2014-11-21 |
4 |
B |
$45.08 |
$22,540 |
D/D |
500 |
11,000 |
2.39 |
- |
|
Farber Jeffrey |
Director |
|
2014-11-19 |
5 |
A |
$0.00 |
$0 |
D/D |
100,000 |
520,595 |
|
- |
|
Farber David |
10% Owner |
|
2014-11-17 |
4 |
AS |
$47.70 |
$238,500 |
D/D |
(5,000) |
43,370 |
|
- |
|
Bedrosian Arthur P |
President and CEO |
|
2014-11-17 |
4 |
AS |
$47.70 |
$238,500 |
D/D |
(5,000) |
628,952 |
|
- |
|
Farber David |
10% Owner |
|
2014-10-30 |
4 |
AS |
$55.00 |
$550,000 |
D/D |
(10,000) |
48,370 |
|
- |
|
Farber David |
10% Owner |
|
2014-10-27 |
4 |
AS |
$50.00 |
$375,000 |
D/D |
(7,500) |
58,370 |
|
- |
|
Farber David |
10% Owner |
|
2014-10-15 |
4 |
AS |
$40.21 |
$201,050 |
D/D |
(5,000) |
65,870 |
|
- |
|
Bedrosian Arthur P |
President and CEO |
|
2014-10-15 |
4 |
AS |
$40.22 |
$201,100 |
D/D |
(5,000) |
633,952 |
|
- |
|
Bedrosian Arthur P |
President and CEO |
|
2014-09-16 |
4 |
AS |
$40.05 |
$200,250 |
D/D |
(5,000) |
638,817 |
|
- |
|
Farber David |
10% Owner |
|
2014-09-16 |
4 |
AS |
$40.05 |
$200,250 |
D/D |
(5,000) |
70,870 |
|
- |
|
Farber David |
10% Owner |
|
2014-08-18 |
4 |
AS |
$41.30 |
$206,500 |
D/D |
(5,000) |
75,870 |
|
- |
|
Bedrosian Arthur P |
President and CEO |
|
2014-08-18 |
4 |
AS |
$41.30 |
$206,500 |
D/D |
(5,000) |
643,817 |
|
- |
|
Taveira Paul |
Director |
|
2014-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
17,500 |
|
- |
|
Drabik David A |
Director |
|
2014-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
27,500 |
|
- |
|
762 Records found
|
|
Page 19 of 31 |
|
|